Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 23:8:168.
doi: 10.3389/fcimb.2018.00168. eCollection 2018.

Heterogeneity of Microbiota Dysbiosis in Chronic Rhinosinusitis: Potential Clinical Implications and Microbial Community Mechanisms Contributing to Sinonasal Inflammation

Affiliations

Heterogeneity of Microbiota Dysbiosis in Chronic Rhinosinusitis: Potential Clinical Implications and Microbial Community Mechanisms Contributing to Sinonasal Inflammation

Keehoon Lee et al. Front Cell Infect Microbiol. .

Abstract

Recent studies leveraging next-generation sequencing and functional approaches to understand the human microbiota have demonstrated the presence of diverse, niche-specific microbial communities at nearly every mucosal surface. These microbes contribute to the development and function of physiologic and immunological features that are key to host health status. Not surprisingly, several chronic inflammatory diseases have been attributed to dysbiosis of microbiota composition or function, including chronic rhinosinusitis (CRS). CRS is a heterogeneous disease characterized by inflammation of the sinonasal cavity and mucosal microbiota dysbiosis. Inflammatory phenotypes and bacterial community compositions vary considerably across individuals with CRS, complicating current studies that seek to address causality of a dysbiotic microbiome as a driver or initiator of persistent sinonasal inflammation. Murine models have provided some experimental evidence that alterations in local microbial communities and microbially-produced metabolites influence health status. In this perspective, we will discuss the clinical implications of distinct microbial compositions and community-level functions in CRS and how mucosal microbiota relate to the diverse inflammatory endotypes that are frequently observed. We will also describe specific microbial interactions that can deterministically shape the pattern of co-colonizers and the resulting metabolic products that drive or exacerbate host inflammation. These findings are discussed in the context of CRS-associated inflammation and in other chronic inflammatory diseases that share features observed in CRS. An improved understanding of CRS patient stratification offers the opportunity to personalize therapeutic regimens and to design novel treatments aimed at manipulation of the disease-associated microbiota to restore sinus health.

Keywords: biofilm; chronic rhinosinusitis; interspecies interaction; microbiome; microbiome-host interaction; microbiota.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Respiratory health is likely affected by homeostasis of bacterial, fungal, and viral communities and their specific interactions. Studies that elucidate these complex interactions are necessary in order to design specific therapeutics that target microbial community dysbiosis in the airways.

References

    1. Abreu N. A., Nagalingam N. A., Song Y., Roediger F. C., Pletcher S. D., Goldberg A. N., et al. . (2012). Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci. Transl. Med. 4:151ra124. 10.1126/scitranslmed.3003783 - DOI - PMC - PubMed
    1. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. . (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236. 10.1038/nature12331 - DOI - PubMed
    1. Azad M. B., Konya T., Maughan H., Guttman D. S., Field C. J., Chari R. S., et al. . (2013). Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185, 385–394. 10.1503/cmaj.121189 - DOI - PMC - PubMed
    1. Bachert C., Zhang N., van Zele T., Gevaert P., Patou J., van Cauwenberge P. (2007). Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin. Allergy Immunol. 20, 163–175. - PubMed
    1. Bhattacharyya N. (2011). Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann. Otol. Rhinol. Laryngol. 120, 423–427. 10.1177/000348941112000701 - DOI - PubMed

Substances